MedPath

White matter lesions in young to middle aged women with stroke, preeclampsia and migraine: a 7Tesla-study

Recruiting
Conditions
Ischemic stroke
migraine
preeclampsia
10007963
10026908
Registration Number
NL-OMON55353
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
160
Inclusion Criteria

- Age between 40 and 60 years
- Ability and willingness to provide written informed consent

Exclusion Criteria

- Our three patient groups (ischemic stroke, preeclampsia and migraine) are
mutually exclusive regarding the defining diagnose, e.g. patients in our
ischemic stroke group cannot have a history of migraine and/or preeclampsia.
- Contra-indications for 3T (migraine and controls) or 7T MRI (all groups).

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Primary outcomes are i) distribution of WML (deep versus subcortical) on FLAIR,<br /><br>ii) total burden of SVD markers associated to WML (4 point score for presence<br /><br>or absence of microbleeds, perivascular spaces, lacunar infarcts and<br /><br>microinfarcts), iii) vasoreactivity measured by BOLD change. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary/exploratory outcomes are i) total WML volume, ii) number and<br /><br>distribution of microbleeds, small infarctions and enlarged perivascular<br /><br>spaces, iii) pulsatility index measured with 2D Qflow, iv) normal appearing<br /><br>white matter on DTI, v) WML in relation to vascular function of the<br /><br>heart-brain axis, vi) WML in relation to cognitive and mood symptoms. In the<br /><br>women with stroke and the women with preeclampsia the 3T MRI has been performed<br /><br>in the CREW-MIST study (Protocol ID: NL54324.058.15) and is not part of this<br /><br>protocol.</p><br>
© Copyright 2025. All Rights Reserved by MedPath